LAURA WILHEM MANLEY: Open Payments
NPI 1649547415 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$850 in 41 payments from 9 companies in 2025. Trend: 2023 $744 · 2024 $583 · 2025 $850
Food & beverage: $747Education: $104
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $300 |
| GlaxoSmithKline, LLC. | 11 | $175 |
| Regeneron Healthcare Solutions, Inc. | 6 | $160 |
| Amgen Inc. | 3 | $71 |
| GENZYME CORPORATION | 3 | $61 |
| Octapharma USA, Inc. | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| Hikma Pharmaceuticals USA | 1 | $20 |
| BioCryst US Sales Co., LLC | 1 | $17 |
Products named: DUPIXENT, BREZTRI, TEZSPIRE, TRELEGY ELLIPTA, AIRSUPRA, NUCALA, PANZYGA, Ryaltris.
Industry payments across KY — which companies pay providers there.
